What Is the Trodelvy Cost in India?

Trodelvy (sacituzumab govitecan-hziy), manufactured by Gilead Sciences, is an antibody-drug conjugate targeting Trop-2, used in adults with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) and HR-positive, HER2-negative breast cancer. Since Trodelvy is not yet approved in India, the cost in India depends on international pricing, import regulations, and logistics under the Named Patient Program (NPP). Pricing may vary based on dosage requirements and treatment cycles. As it is administered via intravenous infusion and may require premedication for side effects such as neutropenia and diarrhea, overall treatment planning is essential. Indian patients can legally access Trodelvy through import channels under NPP. For current cost details and assistance, call or WhatsApp +91 98104 69557.

   For the latest Trodelvy price in India and assistance with documentation, contact our team at +91 98104 69557 for personalized guidance.